{"title":"Positive Psychology Interventions for Improving Self-management Behaviors in Patients with Type 1 and Type 2 Diabetes: a Narrative Review of Current Evidence.","authors":"Lihua Pan, Nelson C Y Yeung","doi":"10.1007/s11892-023-01525-z","DOIUrl":"10.1007/s11892-023-01525-z","url":null,"abstract":"<p><strong>Purpose of review: </strong>Interests have been emerging in using positive psychology interventions (PPIs) to improve diabetes self-management (DSM) behaviors (e.g., blood glucose monitoring, physical activity). To explore the impact of those interventions on DSM behaviors, we summarized the evidence of PPIs on self-management behaviors among both type 1 diabetes (T1D) and type 2 diabetes (T2D) patients between 2012 and 2022.</p><p><strong>Recent findings: </strong>Among the eight studies identified, different study designs and types of PPIs were apparent. Typical PPIs (e.g., activities enhancing positive affect/gratitude/self-affirmation/optimism) were usually applied to T1D patients (N = 5); PPIs were usually combined with motivational interviewing for T2D patients (N = 3). Contrary to expectations, PPIs did not consistently demonstrate positive effects on self-management behaviors' change regardless of the types of diabetes patients, compared to the control groups. Improvements in diabetes patients' self-management behaviors from PPIs are still unclear. Future studies should more rigorously evaluate and identify the active ingredients of PPIs for behavioral changes among diabetes patients.</p>","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":" ","pages":"329-345"},"PeriodicalIF":4.2,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71421481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Current Diabetes ReportsPub Date : 2023-10-01Epub Date: 2023-09-20DOI: 10.1007/s11892-023-01521-3
Katarzyna Wnuk, Jakub Świtalski, Tomasz Tatara, Wojciech Miazga, Sylwia Jopek, Anna Augustynowicz, Urszula Religioni, Mariusz Gujski
{"title":"Workplace Interventions for Type 2 Diabetes Mellitus Prevention-an Umbrella Review.","authors":"Katarzyna Wnuk, Jakub Świtalski, Tomasz Tatara, Wojciech Miazga, Sylwia Jopek, Anna Augustynowicz, Urszula Religioni, Mariusz Gujski","doi":"10.1007/s11892-023-01521-3","DOIUrl":"10.1007/s11892-023-01521-3","url":null,"abstract":"<p><strong>Purpose of review: </strong>Type 2 diabetes mellitus (T2DM) is a chronic disease that may lead to severe complications. The main methods of preventing or delaying the onset of T2DM include lifestyle changes. The purpose of this study is to identify and evaluate the effectiveness of workplace interventions aimed at preventing type 2 diabetes. An umbrella review was conducted in accordance with the Cochrane Collaboration guidelines. Searches were performed in Medline (via PubMed), Embase (via OVID), and Cochrane Library databases. The quality assessment of the included studies was performed using the AMSTAR2 tool.</p><p><strong>Recent findings: </strong>The final analysis included 7 studies. The majority (4 of 7) of the studies included in the review focused on workplace interventions based on the guidelines of the US Diabetes Prevention Program (DPP) or other similar programs. The method of decreasing the risk of type 2 diabetes among employees are programs consisting of multiple approaches aimed at improving parameters associated with diabetes, i.e., body weight, and therefore BMI, reduction, and reducing blood glucose levels, as well as HbA1c levels through educational approach and lifestyle changes. The results of those studies point to multicomponent interventions as more effective than single-component interventions. An effective workplace intervention aimed to reduce the risk of type 2 diabetes among employees is a multicomponent program consisting of elements such as educational activities, interventions targeting dietary changes and increased physical activity.</p>","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":"23 10","pages":"293-304"},"PeriodicalIF":5.2,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520112/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41113594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Graham D Ogle, Gabriel A Gregory, Fei Wang, Thomas I G Robinson, Jayanthi Maniam, Dianna J Magliano, Trevor John Orchard
{"title":"Correction to: The T1D Index: Implications of Initial Results, Data Limitations, and Future Development.","authors":"Graham D Ogle, Gabriel A Gregory, Fei Wang, Thomas I G Robinson, Jayanthi Maniam, Dianna J Magliano, Trevor John Orchard","doi":"10.1007/s11892-023-01524-0","DOIUrl":"10.1007/s11892-023-01524-0","url":null,"abstract":"","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":" ","pages":"305"},"PeriodicalIF":4.2,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520176/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10231075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Current Diabetes ReportsPub Date : 2023-10-01Epub Date: 2023-09-11DOI: 10.1007/s11892-023-01519-x
Alan Reyes-García, Isabel Junquera-Badilla, Carolina Batis, M Arantxa Colchero, J Jaime Miranda, Tonatiuh Barrientos-Gutiérrez, Ana Basto-Abreu
{"title":"How Could Taxes on Sugary Drinks and Foods Help Reduce the Burden Of Type 2 Diabetes?","authors":"Alan Reyes-García, Isabel Junquera-Badilla, Carolina Batis, M Arantxa Colchero, J Jaime Miranda, Tonatiuh Barrientos-Gutiérrez, Ana Basto-Abreu","doi":"10.1007/s11892-023-01519-x","DOIUrl":"10.1007/s11892-023-01519-x","url":null,"abstract":"<p><strong>Purpose of review: </strong>Taxes on sugary drinks and foods have emerged as a key strategy to counteract the alarming levels of diabetes worldwide. Added sugar consumption from industrialized foods and beverages has been strongly linked to type 2 diabetes. This review provides a synthesis of evidence on how taxes on sugary products can influence the onset of type 2 diabetes, describing the importance of the different mechanisms through which the consumption of these products is reduced, leading to changes in weight and potentially a decrease in the incidence of type 2 diabetes.</p><p><strong>Recent findings: </strong>Observational studies have shown significant reductions in purchases, energy intake, and body weight after the implementation of taxes on sugary drinks or foods. Simulation studies based on the association between energy intake and type 2 diabetes estimated the potential long-term health and economic effects, particularly in low- and middle-income countries, suggesting that the implementation of sugary food and beverage taxes may have a meaningful impact on reducing type 2 diabetes and complications. Public health response to diabetes requires multi-faceted approaches from health and non-health actors to drive healthier societies. Population-wide strategies, such as added sugar taxes, highlight the potential benefits of financial incentives to address behaviors and protective factors to significantly change an individual's health trajectory and reduce the onset of type 2 diabetes worldwide, both in terms of economy and public health.</p>","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":" ","pages":"265-275"},"PeriodicalIF":4.2,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10206491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Current Diabetes ReportsPub Date : 2023-10-01Epub Date: 2023-08-23DOI: 10.1007/s11892-023-01520-4
Graham D Ogle, Gabriel A Gregory, Fei Wang, Thomas Ig Robinson, Jayanthi Maniam, Diana J Magliano, Trevor John Orchard
{"title":"The T1D Index: Implications of Initial Results, Data Limitations, and Future Development.","authors":"Graham D Ogle, Gabriel A Gregory, Fei Wang, Thomas Ig Robinson, Jayanthi Maniam, Diana J Magliano, Trevor John Orchard","doi":"10.1007/s11892-023-01520-4","DOIUrl":"10.1007/s11892-023-01520-4","url":null,"abstract":"<p><strong>Purpose of the review: </strong>Current global information on incidence, prevalence, and mortality of type 1 diabetes (T1D) is limited, particularly in low- and middle-income countries. To address this gap in evidence, JDRF, Life for a Child, International Society for Pediatric and Adolescent Diabetes, and International Diabetes Federation have developed the T1D Index, which uses a Markov mathematical model, and machine learning and all available data to provide global estimates of the burden on T1D. This review assesses the methodology, limitations, current findings, and future directions of the Index.</p><p><strong>Recent findings: </strong>Global prevalence was estimated at 8.4 million in 2021, with 1.5 million <20 years (y). T1D prevalence varied from 1.5 to 534 per 100,000, with T1D accounting for <0.1-17.8% of all diabetes in different countries. A total of 35,000 young people <25 y are estimated to have died at clinical onset of T1D from non-diagnosis. An estimated 435,000 people <25 y were receiving \"minimal care.\" Health-adjusted life years (HALYs) lost for individuals diagnosed with T1D at age 10 y in 2021 ranged from 14 to 55 y. These results show that interventions to reduce deaths from non-diagnosis, and improve access to at least an intermediate care level, are needed to reduce projected life years lost. The results have significant uncertainties due to incomplete data across the required inputs. Obtaining recent incidence, prevalence, and mortality data, as well as addressing data quality issues, misdiagnoses, and the lack of adult data, is essential for maintaining and improving accuracy. The index will be updated regularly as new data become available.</p>","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":" ","pages":"277-291"},"PeriodicalIF":4.2,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520097/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10283162","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Current Diabetes ReportsPub Date : 2023-10-01Epub Date: 2023-08-03DOI: 10.1007/s11892-023-01518-y
Ziyue Zhu, Samuel Yeung Shan Wong, Joseph Jao Yiu Sung, Thomas Yuen Tung Lam
{"title":"Team-Based Approach to Reduce Malignancies in People with Diabetes and Obesity.","authors":"Ziyue Zhu, Samuel Yeung Shan Wong, Joseph Jao Yiu Sung, Thomas Yuen Tung Lam","doi":"10.1007/s11892-023-01518-y","DOIUrl":"10.1007/s11892-023-01518-y","url":null,"abstract":"<p><strong>Purpose of review: </strong>Numerous observations have indicated an increased risk of developing various types of cancers, as well as cancer-related mortality, among patients with diabetes and obesity. The purpose of this review is to outline multiple-cancer screening among these patients through a team-based approach and to present the findings of a pioneering integrated care program designed for patients with obesity with a specific emphasis on cancer prevention.</p><p><strong>Recent findings: </strong>A community-based multi-cancer prevention program, which provides all services in one location and utilizes team-based approaches, is reported to be feasible and has the potential to enhance the uptake rate of multiple cancers screening among patients with diabetes and obesity. The team-based approach is a commonly utilized method for managing patients with diabetes, obesity, and cancer, and has been shown to be efficacious. Nevertheless, research on team-based cancer screening programs for patients with diabetes and obesity remains limited. Providing a comprehensive screening for colorectal, prostate, and breast cancer, as well as metabolic syndrome, during a single clinic visit has been proven effective and well-received by participants.</p>","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":" ","pages":"253-263"},"PeriodicalIF":4.2,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520129/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9918687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yitayeh Belsti, Lisa Moran, Demelash Woldeyohannes Handiso, Vincent Versace, Rebecca Goldstein, Aya Mousa, Helena Teede, Joanne Enticott
{"title":"Models Predicting Postpartum Glucose Intolerance Among Women with a History of Gestational Diabetes Mellitus: a Systematic Review.","authors":"Yitayeh Belsti, Lisa Moran, Demelash Woldeyohannes Handiso, Vincent Versace, Rebecca Goldstein, Aya Mousa, Helena Teede, Joanne Enticott","doi":"10.1007/s11892-023-01516-0","DOIUrl":"https://doi.org/10.1007/s11892-023-01516-0","url":null,"abstract":"<p><strong>Purpose of review: </strong>Despite the crucial role that prediction models play in guiding early risk stratification and timely intervention to prevent type 2 diabetes after gestational diabetes mellitus (GDM), their use is not widespread in clinical practice. The purpose of this review is to examine the methodological characteristics and quality of existing prognostic models predicting postpartum glucose intolerance following GDM.</p><p><strong>Recent findings: </strong>A systematic review was conducted on relevant risk prediction models, resulting in 15 eligible publications from research groups in various countries. Our review found that traditional statistical models were more common than machine learning models, and only two were assessed to have a low risk of bias. Seven were internally validated, but none were externally validated. Model discrimination and calibration were done in 13 and four studies, respectively. Various predictors were identified, including body mass index, fasting glucose concentration during pregnancy, maternal age, family history of diabetes, biochemical variables, oral glucose tolerance test, use of insulin in pregnancy, postnatal fasting glucose level, genetic risk factors, hemoglobin A1c, and weight. The existing prognostic models for glucose intolerance following GDM have various methodological shortcomings, with only a few models being assessed to have low risk of bias and validated internally. Future research should prioritize the development of robust, high-quality risk prediction models that follow appropriate guidelines, in order to advance this area and improve early risk stratification and intervention for glucose intolerance and type 2 diabetes among women who have had GDM.</p>","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":"23 9","pages":"231-243"},"PeriodicalIF":4.2,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435618/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10046697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Current Diabetes ReportsPub Date : 2023-09-01Epub Date: 2023-06-09DOI: 10.1007/s11892-023-01514-2
Casey A Droske, Triniece N Pearson, Sharon J Velkovich, Hannah Cohn, Jacqueline M Kanoon, Arshiya A Baig, Valerie G Press
{"title":"Variations in the Design and Use of Attention Control Groups in Type 2 Diabetes Randomized Controlled Trials: a Systematic Review.","authors":"Casey A Droske, Triniece N Pearson, Sharon J Velkovich, Hannah Cohn, Jacqueline M Kanoon, Arshiya A Baig, Valerie G Press","doi":"10.1007/s11892-023-01514-2","DOIUrl":"10.1007/s11892-023-01514-2","url":null,"abstract":"<p><strong>Purpose of review: </strong>In type 2 diabetes (T2D) research, the phrase \"attention control group\" (ACGs) has been used with varying descriptions. We aimed to systematically review the variations in the design and use of ACGs for T2D studies.</p><p><strong>Recent findings: </strong>Twenty studies utilizing ACGs were included in the final evaluation. Control group activities had the potential to influence the primary outcome of the study in 13 of the 20 articles. Prevention of contamination across groups was not mentioned in 45% of the articles. Eighty-five percent of articles met or somewhat met the criteria for having comparable activities between the ACG and intervention arms. Wide variations in descriptions and the lack of standardization have led to an inaccurate use of the phrase \"ACGs\" when describing the control arm of trials, indicating a need for future research with focus on the adoption of uniform guidelines for use of ACGs in T2D RCTs.</p>","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":"23 9","pages":"217-229"},"PeriodicalIF":5.2,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527690/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10027172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Qiuling An, Zhan Yu, Fei Sun, Jiaxuan Chen, Anao Zhang
{"title":"The Effectiveness of Cognitive Behavioral Therapy for Depression Among Individuals with Diabetes: a Systematic Review and Meta-Analysis.","authors":"Qiuling An, Zhan Yu, Fei Sun, Jiaxuan Chen, Anao Zhang","doi":"10.1007/s11892-023-01517-z","DOIUrl":"https://doi.org/10.1007/s11892-023-01517-z","url":null,"abstract":"<p><strong>Purpose of review: </strong>Depression is prevalent and common among individuals living with diabetes. The aim of this review is to systematically assess and meta-analyze the treatment effect of cognitive-behavioral therapy for depression (and other affective outcomes) among patients with diabetes.</p><p><strong>Recent findings: </strong>Earlier investigations found both psychosocial and pharmacological interventions, including cognitive-behavioral therapy, were promising in managing depression in patients with diabetes, though these findings remain inclusive due to poor study designs and a small number of trials included, which calls for a comprehensive systematic review and meta-analysis. A total of 33 studies (89 effect sizes) reported a moderate and statistically significant treatment effect of cognitive-behavioral therapy for depressive symptoms among individuals with diabetes (d = 0.301, 95% CI 0.115-0.487, p < 0.001). On average, cognitive-behavioral therapy was effective for psychological stress/distress outcomes but not for anxiety or physiological outcomes. The findings of the study confirmed CBT as an effective treatment option for depression among diabetes patients and identified important areas for future research.</p>","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":"23 9","pages":"245-252"},"PeriodicalIF":4.2,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10094319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Current Diabetes ReportsPub Date : 2023-08-01Epub Date: 2023-06-07DOI: 10.1007/s11892-023-01515-1
Rachel Wong, Emily Lam, Carolyn T Bramante, Steven G Johnson, Jane Reusch, Kenneth J Wilkins, Hsin-Chieh Yeh
{"title":"Does COVID-19 Infection Increase the Risk of Diabetes? Current Evidence.","authors":"Rachel Wong, Emily Lam, Carolyn T Bramante, Steven G Johnson, Jane Reusch, Kenneth J Wilkins, Hsin-Chieh Yeh","doi":"10.1007/s11892-023-01515-1","DOIUrl":"10.1007/s11892-023-01515-1","url":null,"abstract":"<p><strong>Purpose of review: </strong>Multiple studies report an increased incidence of diabetes following SARS-CoV-2 infection. Given the potential increased global burden of diabetes, understanding the effect of SARS-CoV-2 in the epidemiology of diabetes is important. Our aim was to review the evidence pertaining to the risk of incident diabetes after COVID-19 infection.</p><p><strong>Recent findings: </strong>Incident diabetes risk increased by approximately 60% compared to patients without SARS-CoV-2 infection. Risk also increased compared to non-COVID-19 respiratory infections, suggesting SARS-CoV-2-mediated mechanisms rather than general morbidity after respiratory illness. Evidence is mixed regarding the association between SARS-CoV-2 infection and T1D. SARS-CoV-2 infection is associated with an elevated risk of T2D, but it is unclear whether the incident diabetes is persistent over time or differs in severity over time. SARS-CoV-2 infection is associated with an increased risk of incident diabetes. Future studies should evaluate vaccination, viral variant, and patient- and treatment-related factors that influence risk.</p>","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":"23 8","pages":"207-216"},"PeriodicalIF":4.2,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244847/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9793364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}